PR001913 (Project)

Description:Colonization of the human stomach with H. pylori strains producing active forms of a secreted toxin (VacA) is associated with an increased risk of peptic ulcer disease and gastric cancer, compared to colonization with strains producing hypoactive forms of VacA. Previous studies have shown that VacA causes cell vacuolation and mitochondrial dysfunction. In this study, we sought to define the cellular metabolic consequences of VacA intoxication. Untargeted metabolomic analyses revealed that several hundred metabolites were significantly altered in VacA-treated gastroduodenal cells (AGS and AZ-521) compared to control cells. Pathway analysis suggested that VacA caused alterations in taurine and hypotaurine metabolism. Treatment of cells with the purified active s1m1 form of VacA, but not hypoactive s2m1 or Delta_6-27 VacA mutant proteins (defective in membrane channel formation), caused reductions in taurine and hypotaurine levels. Supplementation of the tissue culture medium with taurine or hypotaurine protected AZ-521 cells against VacA-induced cell death. Untargeted global metabolomics of AZ-521 cells or AGS cells intoxicated with VacA in the presence or absence of extracellular taurine showed that taurine was the main intracellular metabolite significantly altered by extracellular taurine supplementation. These results indicate that VacA causes alterations in cellular taurine metabolism and indicate that repletion of taurine is sufficient to attenuate VacA-induced cell death.
Results found

Linked to

 

Label

Description

 

Biosample

A biosample from Metabolomics produced as part of the PR001913 project

Biosample

A biosample from Metabolomics produced as part of the PR001913 project

File

A 17.6 GB file from Metabolomics produced from OBI:0003097 as part of the PR001913 project

Biosample

A biosample from Metabolomics produced as part of the PR001913 project

Biosample

A biosample from Metabolomics produced as part of the PR001913 project

Biosample

A biosample from Metabolomics produced as part of the PR001913 project

Biosample

A biosample from Metabolomics produced as part of the PR001913 project

File

A 473 KB file from Metabolomics produced from OBI:0003097 as part of the PR001913 project

Biosample

A biosample from Metabolomics produced as part of the PR001913 project

Biosample

A biosample from Metabolomics produced as part of the PR001913 project

  • Biosample

    A biosample from Metabolomics produced as part of the PR001913 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001913 project


  • File

    A 17.6 GB file from Metabolomics produced from OBI:0003097 as part of the PR001913 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001913 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001913 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001913 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001913 project


  • File

    A 473 KB file from Metabolomics produced from OBI:0003097 as part of the PR001913 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001913 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001913 project

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.